LUIS ALBERTO
RUIZ ITURRIAGA
Hospital Universitario de Cruces
Barakaldo, EspañaPublications in collaboration with researchers from Hospital Universitario de Cruces (37)
2024
-
Basic host response parameters to classify mortality risk in COVID-19 and community-acquired pneumonia
Scientific reports, Vol. 14, Núm. 1, pp. 12726
2023
-
Dyspnoea after epileptic seizures: beyond aspiration pneumonia
Internal and Emergency Medicine
-
High-flow nasal cannula oxygen therapy for the treatment of acute respiratory failure secondary to SARS-CoV-2 pneumonia out of ICU
Clinical Respiratory Journal, Vol. 17, Núm. 9, pp. 905-914
-
Impact of outdoor air pollution on severity and mortality in COVID-19 pneumonia
Science of the Total Environment, Vol. 894
-
Impact of severe lymphopenia on the early prediction of clinical outcome in hospitalized patients with pneumococcal community-acquired pneumonia
Infection, Vol. 51, Núm. 5, pp. 1319-1327
-
Is the long-term mortality similar in COVID-19 and community-acquired pneumonia?
Frontiers in Medicine, Vol. 10
-
Short- and long-term prognosis of patients with community-acquired Legionella or pneumococcal pneumonia diagnosed by urinary antigen testing
International Journal of Infectious Diseases, Vol. 134, pp. 106-113
-
Ten Issues for Updating in Community-Acquired Pneumonia: An Expert Review
Journal of Clinical Medicine, Vol. 12, Núm. 21
-
Validation of IDSA/ATS Guidelines for ICU Admission in Adults Over 80 Years Old With Community-Acquired Pneumonia
Archivos de Bronconeumologia, Vol. 59, Núm. 1, pp. 19-26
2022
-
Bacteraemic pneumococcal pneumonia and SARS-CoV-2 pneumonia: differences and similarities
International Journal of Infectious Diseases, Vol. 115, pp. 39-47
-
Bacteremic pneumococcal pneumonia: arrhythmogenic disease
Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia
-
COVID-19 in young and middle-aged adults: predictors of poor outcome and clinical differences
Infection, Vol. 50, Núm. 1, pp. 179-189
-
Early Recognition of Low-Risk SARS-CoV-2 Pneumonia: A Model Validated With Initial Data and Infectious Diseases Society of America/American Thoracic Society Minor Criteria
Chest, Vol. 162, Núm. 4, pp. 768-781
-
Estimating the risk of bacteraemia in hospitalised patients with pneumococcal pneumonia
Journal of Infection, Vol. 85, Núm. 6, pp. 644-651
2021
-
New-onset atrial fibrillation in patients with pneumococcal pneumonia. Impact of timing and duration on short- and medium-term mortality
Journal of Infection, Vol. 82, Núm. 1, pp. 67-75
-
Pulmonary Function in Early Follow-up of patients with COVID-19 Pneumonia
Archivos de Bronconeumologia, Vol. 57, pp. 75-76
-
RDW-based clinical score to predict long-term survival in community-acquired pneumonia: a European derivation and validation study
Internal and Emergency Medicine, Vol. 16, Núm. 6, pp. 1547-1557
2020
-
Non-bacteremic pneumococcal pneumonia: general characteristics and early predictive factors for poor outcome
Infectious Diseases, Vol. 52, Núm. 9, pp. 603-611
2019
-
Evolution of serotypes in bacteremic pneumococcal adult pneumonia in the period 2001–2014, after introduction of the pneumococcal conjugate vaccine in bizkaia (spain)
Vaccine, Vol. 37, Núm. 29, pp. 3840-3848
-
Factors influencing long-term survival after hospitalization with pneumococcal pneumonia
Journal of Infection, Vol. 79, Núm. 6, pp. 542-549